Indivior PLC

Indivior insider buys: Daniel Ninivaggi and peers buy 775 shares each at market price, signaling confidence in the pipeline and steady growth prospects.

Indivior insider buying signals confidence: Ryan Barbara and 16 others buy shares, hinting the drugmaker’s valuation may be undervalued amid a rebound in the substance‑use‑disorder market.